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Background: Kaliziri extract (KZE) is a traditional Uyghur medicine (TUM), used by traditional hospitals in China as
an injection for treatment of vitiligo for more than 30 years. Clinical application has shown that this medicine has
obvious therapeutic effects. However, its phytochemical analysis and mechanism have not been examined.
Methods: KZE was extracted from seeds of Kaliziri [Vernonia anthelmintica (L.) Willd.] in ethanol-water (80:20, v/v), its
components were identified by LC-MS/MS, and the signaling pathway of melanin synthesis in KZE treated
murine B16 melanoma cells was examined by western blotting.
Results: Liquid chromatography-mass spectrometry analysis confirmed that the main components of KZE are
flavonoids. KZE increased the tyrosinase activity and melanin content in a dose-dependent manner at concentrations
of 5-40 μg/ml, and treatment with 20 μg/ml of KZE enhanced the expression of tyrosinase in B16 cells in a
time-dependent manner.
Conclusions: KZE induced melanogenesis by increasing the expression of TYR, TRP-1, TRP-2 and MITF in B16 cells.
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Traditional Uyghur medicine (TUM), one of the main
medicinal systems in central Asia, is based on four hu-
mors: fire, air, water and earth, which generate four dif-
ferent body fluids: blood, phlegm, yellow bile and black
bile [1]. The main ingredients of TUM are flowers, seeds,
fruits, minerals and animal compartments. According to
the TUM theory, diseases or impairments result from an
imbalance between the four body fluids. TUM herbal for-
mulation can regulate the balance of body fluids and cure
diseases [2].
Kaliziri [Vernonia anthelmintica (L.) Willd.] is a plant
that only grows in high-altitude areas of southern Xinjiang
and small regions in Pakistan and India. Kaliziri is an* Correspondence: haji@ms.xjb.ac.cn
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article, unless otherwise stated.erect, pubescent, annual herb, and its length is up to
90 cm. The leaves of this plant are elliptic lanceolate, 5 to
9 cm long and 2.5 to 3.2 cm wide, with apex acute, base
tapering into the petiole, margins coarsely serrated, and
pubescence found on both surfaces of the leaf. The Kaliziri
florets are hairy and are violet or purple in color, and blos-
som in abundance, with homogenous, solitary, axillary or
terminal heads that are 1.3 to 2 cm in diameter, with a lin-
ear bract near the top of the peduncle. The fruit are 4.5 to
6 mm long, oblong-cylindrical in shape and have 10 pu-
bescent ribs.
Kaliziri is a Uyghur medicinal plant vastly used for
treating diseases and is considered as highly therapeutic.
The seeds are used as febrifuge for treating skin diseases
like leukoderma (also named vitiligo) in traditional ther-
apy. Vitiligo is called “baras” or “akbaras” in TUM. TUM
has a long history of several centuries; its origin can be
traced back to antiquity. During a long course of strug-
gling with diseases, TUM evolved into a unique and in-
tegrated theoretical system. However, TUM also has a
unique method and theory in the treatment of vitiligo.ntral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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adiwiya” (Persian, Muhammad huseyin. Mu calendar 1183,
AD 1763), the ancient Uyghur doctors accumulated a lot
of experience with the Uyghur medical treatment of vitiligo
using the traditional method and continuous innovation,
and this experience has been widely implemented in the
treatment of vitiligo at home and abroad because of its
effectiveness. The TUM Kaliziri injection was extracted
from Kaliziri seeds by a scientific method (Pharmacopoeia
of the People’s Republic of China, Uyghur Medicine
volume, product with code number approved by SFDA:
Z20063652) [3]. Its main components are flavonoids. Clin-
ical application over many years has shown that this medi-
cine has a significant therapeutic effect on vitiligo; hence
Kaliziri extract is a commonly used drug for the treatment
of vitiligo. This drug has been used for more than 30 years
in Xinjiang. It is safe and reliable, as unlike drugs such
as the psoralen class, it has no side effects on important
organs such as liver and kidney, and children can use it.
According to the TUM theory, Kaliziri can treat diseases
through balancing the Mizaj in the liver, and eliminating
abnormal Balgham Hilit (damp and cold) by excreting
dampness. It is capable of regulating abnormal balgham
by promoting blood circulation and coloring by increas-
ing melanin cell function. Nonetheless, its effect and
underlying mechanisms in melanogenesis are not very
clear. The aim of this study was to clarify the effect of
Kaliziri extract (KZE) and its molecular mechanism in
melanin biosynthesis in B16 melanoma cells.
Vitiligo is an acquired, progressive, multifactorial, de-
pigmentation disorder characterized by the appearance
of circumscribed white macules in the skin caused by
chronic, progressive loss of functional melanocytes in the
epidermis [4,5]. Vitiligo affects 1-2% of the population
worldwide, with no predilection for gender or race, and
usually starts in childhood or young adulthood. Manifesta-
tions begin before 20 years of age in 50% of the cases,
while in 25% the onset is before 14 years of age [6].
The etiology of vitiligo is poorly understood. There ap-
pears to be a genetic predisposition in a non-Mendelian
pattern, with a polygenic and multi factorial inheritance.
Numerous factors have been implicated in the develop-
ment of vitiligo, including: stress, trauma, exposure to
sunlight, infections, malignancies, neural abnormalities,
melatonin receptor dysfunction, impaired melanocyte mi-
gration, certain drugs, endocrine diseases and cytotoxic
compounds. These causal factors may act independently
or in concert [7]. Pigmentation of the skin serves a num-
ber of valuable functions; perhaps foremost among these
is the photo protection of underlying tissues from ultra-
violet (UV) radiation.
Melanocytes respond to a wide variety of intrinsic and
extrinsic factors produced by the environment or by
neighboring cells in the skin, including UV, melanocytestimulating hormone (MSH), agouti signal protein (ASP),
endothelin 1 (ET1), dickkopf 1 (DKK1), a wide variety of
growth factors, and cytokines [8,9]. The essential function
of tyrosinase in melanin biosynthesis has been known for
many decades. Melanin biosynthesis is catalyzed by three
melanocyte-specific enzymes: TYR, tyrosinase-related pro-
tein 1 (TRP-1) and TRP-2 [10,11]. TYR is the rate-limiting
enzyme in melanogenesis [12], catalyzing the hydroxylation
of tyrosine to form 3, 4-dihydroxyphenylalanine (DOPA),
followed by oxidation of DOPA to produce DOPA-quinone
[13]. Therefore, inhibitors of TYR have been used in cos-
metics as skin-whitening agents [14]. TRP-2 acts as a
dopachrome tautomerase and catalyzes the rearrangement
of dopachrome to form 5, 6-dihydroxyindole-2-carboxylic
acid (DHICA) [15], and TRP-1 oxidizes DHICA to pro-
duce carboxylate indole-quinon [16]. TRP-1 and TRP-2
also function in the biosynthesis of melanin downstream
of TYR. The tyrosinase family genes, TYR, TRP-1 and
TRP-2, are tightly regulated by microphthalmia-associated
transcription factor (MITF) [11,17,18].
MITF is the most important transcription factor in-
volved in the regulation of TYR gene expression, which
is involved in the pigmentation, proliferation and survival
of melanocytes [19,20], thus MITF plays a pivotal role in
melanogenesis [21,22]. It has been reported to bind to the
M-box within the TYR promoter, and thus up regulate
TYR gene expression [23].
The current study identified the main components of
KZE and investigated the effect of KZE on mushroom
TYR activity. We also examined the TYR activity and
melanin content in B16 melanoma cells, as well as the
expression of TYR, TRP-1, TRP-2 and MITF in B16 cells.
Methods
Reagents
Dimethylsulfoxide (DMSO), mushroom tyrosinase, L-3, 4-
dihydroxyphenylalanine (L-DOPA), and 3-(4, 5-dimethyl-
thiazol-2-yl)-2, 5-diphenyl tetrazolium bromide (MTT)
were purchased from SIGMA (St. Louis, MO, USA).
β-actin antibodies were purchased from Cell Signaling
Technology (Danvers, MA, USA) and horseradish
peroxidase-conjugated secondary antibodies were from
GE Healthcare (Piscataway, NJ, USA). TYR, MITF, TRP-1
and TRP-2 antibodies were from Santa Cruz Biotechnology
(Santa Cruz, CA, USA). Enhanced Bradford protein assay
kit was from Beijing Biomed Co.LTD (Beijing, China). Phe-
nylmethylsulfonyl fluoride (PMSF) and the components of
the whole cell lysis buffer for western blot analysis were
purchased from SIGMA (St. Louis, MO, USA).
Preparation of KZE
The whole plants of Kaliziri were identified by professor
Guanmian Sheng, Xinjiang Institute of Ecology and Geog-
raphy, Chinese Academy of Science, China. A voucher
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Xinjiang Key Laboratory of Plant Resources and Natural
Products Chemistry, Xinjiang Technical Institute of Phys-
ics and Chemistry, Chinese Academy of Sciences, China.
250 g of Kaliziri [Vernonia anthelmintica (L.) Willd.]
seeds (identify by Prof. Guan-mian Sheng from Xinjiang
Institute of Ecology and Geography, Chinese Academy of
Sciences) were soaked in 2.5 L of ethanol–water (80:20, v/v)
for 1h at room temperature. Then, the extract was filtered
and the filtrate was evaporated under reduced pressure
using centrifuge to obtain the ethanol extract, with a yield
of 3.38% w/w of the dry weight of the seeds (Pharma-
copoeia of the People’s Republic of China, Uyghur Medicine
volume) [3].
After drying, a dark brown paste was obtained and then
dissolved in PBS. A stock solution of KZE (5 mg/ml) was
prepared in PBS for further applications.
LC-MS/MS analysis
Liquid chromatography-mass spectrometry (LC-MS/MS)
analysis was performed on an Agilent series 1100 HPLC
instrument (Agilent, Waldbronn, Germany) coupled with a
QSTAR Elite System (AB-Sciex, Framingham, MA, USA).
The chromatographic separation was achieved on a Waters
XSELECT C18 column (2.5 μm, ID 2.1 mm × 100 mm).
Mobile phase A was water with 0.1% formic acid and
mobile B was acetonitrile. The eluting conditions were
optimized as follows: 0–3 min, 5% B; 3–53 min, 5–85%
B; 53–63 min, 85–100%; 63–80 min, 100% B. The liquid
flow rate was set at 0.2 ml/min. The HPLC effluent was
introduced into a mass spectrometer without spitting.
The column temperature was 25°C. The injection volume
was 5 μl. A QSTAR Elite System Hybrid Quadrupole-TOF
LC/MS/MS mass spectrometer coupled with electron
spray ionization (ESI) interface was used to obtain the MS/
MS data using Analyst QS 2.0 software. The ionization con-
ditions were optimized and the following conditions were
used: ion spray voltage (IS) 4500 V; curtain gas (CUR) 35
psi; collision gas (CAD) 5 psi; temperature (TEM) 450°C;
ion source gas 1 (GS1) 60 psi; ion source gas 2 (GS2) 50
psi; declusterin potential (DP) 60 V; focusing potential (FP)
350 V; collision energy (CE) 60 V for positive ion mode. Ion
spray voltage (IS)-4300 V; curtain gas (CUR) 35 psi; colli-
sion gas (CAD) 5 psi; temperature (TEM) 500°C; ion source
gas 1 (GS1) 60 psi; ion source gas 2 (GS2) 50 psi; decluster
in potential (DP)-60 V; focusing potential (FP)-350 V; colli-
sion energy (CE)-45 V for negative ion mode. The detection
was conducted considering a mass range of 100–1500 m/z.
Measurement of mushroom tyrosinase activity
The effects on mushroom tyrosinase activity were deter-
mined in a cell-free system using mushroom tyrosinase
following the method reported by Aoki et al. [24]. Eighty
microliters of mushroom tyrosinase at 25U/mol wereused. After adding L-DOPA (2.5 mM), the reaction mix-
ture was incubated for a further 20 min at 37°C. Tyro-
sinase activity was determined by the absorbance at 490
nm of the reaction mixture, and compared with the con-
trol value [24].
Cell culture
The murine B16 melanoma cell line was obtained from
CAS (Chinese Academy of Sciences, China). B16 cells
were grown in DMEM medium (Gibco, Life Technolo-
gies, USA) supplemented with 10% heat-inactivated fetal
bovine serum (Gibco), 100 U/ml penicillin and 100 μg/ml
streptomycin (Hyclone, USA) in a humidified atmosphere
with 5% CO2 at 37°C.
Cell viability assay
Cell viability was determined using the MTT assay. B16
cells were plated in 96-well dishes at a density of 5 ×
103 cells per well. After 24 h, different concentrations
of KZE were added and the cells were incubated for 48 h.
Then, 10 μl of MTT (5 mg/ml in PBS) solution were added
into each well and cells were incubated at 37°C for another
4 h. Following medium removal, 150 μl of DMSO were
added to each well and plates were gently shaken for 10
min. Optical absorbance was determined at 570 nm with a
Spectra Max M5 (Molecular Devices, USA). Absorbance of
cells without treatment was regarded as 100% cell survival.
Each treatment was performed in quintuplicate and each
experiment was repeated three times.
Tyrosinase activity and melanin content assay
Tyrosinase activity was estimated by measuring the rate
of L-DOPA oxidation as previously reported [25]. B16
cells were seeded in a 12-well plate at a density of 2 ×
105 cells per well and allowed to attach for 24 h. Then,
cells were treated with KZE for 48 h, washed with ice-
cold PBS twice, trypsinized with 0.25% trypsin (Hyclone)
and collected in an Ep tube. After centrifuged at 3,000
rpm for 5 min the cells were washed once with PBS, and
then 200 μl of Tris-0.1% Triton X-100 (pH6.8) were added
to each tube. All tubes were incubated at −20°C for 30
min, and then the lysates were centrifuged at 12,000 rpm
for 15 min to obtain the supernatant for the tyrosinase ac-
tivity assay. Protein concentrations were determined by the
Bradford method with bovine serum albumin (BSA) as a
standard. 100 ml of supernatant containing 10 μg total pro-
tein were added to each well in a 96-well plate, and then
mixed with 100 μl of 0.1% L-DOPA in PBS (pH6.8). After
incubation at 37°C for 1 h, the dopachrome was monitored
by measuring the absorbance at 475 nm.
The total melanin in the cell pellet was dissolved in
100 ml of 1M NaOH/10% DMSO for 1 h at 80°C and
solubilized melanin was measured at 470 nm.
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B16 melanoma cells were seeded in 60-mm dishes at a
density of 1 × 106 cells per dish and treated with 20 μg/
ml of KZE for five periods of time (0,12,24,48 and 72 h).
The dishes were washed twice with cold PBS and lysed
in cold whole cell lysis buffer [1 mM phenylmethylsulfo-
nyl fluoride (PMSF), 50 mM KCl, 1% NP-40, 25 mM
HEPES (pH7.8) 100 μg/ml leupeptin, 20 μg/ml aprotinin,
125 μM DTT, 1 mM Na3VO4]. 30 μg of protein from each
sample were added to sodium dodecyl sulfate (SDS)
sample buffer and proteins were separated by 10% poly-
acrylamide gel electrophoresis. Following electrotransfer
to polyvinylidene fluoride (PVDF) membranes, the mem-
branes were blocked with 2% BSA and 0.1% Tween20 in
0.01 M Tris–HCl buffered saline (TBS) for 1 h at room
temperature. After three washes with TBS containing 0.1%
Tween20 (TBST), membranes were incubated overnight
at 4°C with TYR, MITF, TRP-1, TRP-2 (diluted 1: 200) or
β-actin (diluted 1:1000) antibodies in TBST containing 5%
BSA. After three washes with TBST and three washes withFigure 1 LC–MS/MS analyze of KZE. Compounds detected in KZE in n
described in the text.TBS, the membranes were incubated with horseradish
peroxidase-conjugated secondary antibodies at a dilution
of 1:10000 for 1 h at room temperature. After washing with
TBST and TBS, proteins were visualized by ECL western
blotting detection reagents (GE Healthcare). Densitometric
analysis was performed using Quantity One (Bio-Rad,
Hercules, CA, USA) to scan the signals. Western blot assay
results reported here are representative of at least three in-
dependent experiments.
Statistical analysis
All data are expressed as mean ± SEM. Statistical analysis
was performed with one-way ANOVA followed by Tukey’s
post hoc test for multiple comparison tests. Significant dif-
ferences were accepted when P < 0.05.
Results and discussion
Kaliziri is a well-known herb, traditionally used as a pig-
mentation improving medicine for vitiligo in Xinjiang by
the Uyghur people. KZE is extracted from Kaliziri seeds,egative and positive MRM mode. LC–MS/MS conditions as
Tuerxuntayi et al. BMC Complementary and Alternative Medicine 2014, 14:166 Page 5 of 9
http://www.biomedcentral.com/1472-6882/14/166and here we show that its main components are flavonoids
(Figure 1 and Table 1). Long-term clinical application has
shown that this medicine has an obvious therapeutic effect
on vitiligo. However, its mechanisms in melanogenesis
remain unknown.
Liquid chromatography-mass spectrometry analysis of KZE
In our study, 15 compounds composing KZE were
identified and characterized by LC-MS/MS (Figure 1
and Table 1). Eight of them are flavonoids: 5, 7, 3′, 4′-
tetrahydroxy-flavonone-3-O-glucoside, 3′-methoxy-5,7,4′-
trihydroxy-dihydrochalcone-3-O-rutinoside, liquiritigenin,
luteolin, butein, apigenin, methoxy isorhamnetin, kaemp-
feride. The analysis confirmed that the main components
of KZE are flavonoids. In the next phase of the study, the
sources and structures of these compounds need to be
confirmed, to find out which are the active materials.
Effects on mushroom tyrosinase activity
The effect of KZE on mushroom tyrosinase activity was
subsequently investigated in vitro. The results show that
at five different concentrations KZE increased the tyro-
sinase activity in a dose-dependent manner (Figure 2).
Cytotoxicity of KZE in B16 melanoma cells
The effect of KZE on the viability of B16 melanoma cells
was examined using the MTT assay. The cells were treated
with various concentrations of KZE (6.25, 12.5, 25, 50, 100,
200, 400 and 800 μg/ml). As shown in Figure 3, the IC50 of
KZE is 413 μg/ml, and there was no significant difference
between the control and treated group at concentrations ofTable 1 LC–MS/MS characteristics of KZI in MRM mode
No. Compound Peak retentio
time (min)






5 3,4-di-O-caffeoylisoquinic acid 25.06









15 Vernodalin 25.736.25–200 μg/ml. KZE showed very small cytotoxic effects
on B16 cells.Effect of KZE on tyrosinase activity and melanin synthesis
in B16 cells
The effect of KZE on tyrosinase was measured by L-
DOPA oxidation (Figure 3). Compared with treatment
with medium only (untreated condition), treatment with
KZE at 5–40 μg/ml resulted in a dose-dependent in-
crease in tyrosinase activity in B16 cells (Figure 4A). In
the melanin content assay, to exclude the possibility that
a rise in melanin content maybe induced by the cell-
proliferating effect of KZE, the absorbance of the same
number of cells across KZE concentrations (5–40 μg/ml)
was measured. We found that melanin levels increased
in a dose-dependent manner by KZE treatment in B16
cells (Figure 4B). At 40 μg/ml of KZE, the melanin content
only slightly increased, so 20 μg/ml was chosen as an ef-
fective concentration of KZE for further experiments.Effect of KZE on MITF and TYR protein expression in
B16 cells
Because KZE increased tyrosinase activity and melanin
synthesis, we further explored whether KZE affects the
expression of MITF, which plays a critical role in TYR gene
expression and melanogenesis. We examined the MITF
levels after KZE (20 μg/ml) treatment. Our data showed
that MITF protein expression was significantly enhanced
24 h after KZE treatment of B16 cells (Figure 5). The effect
of KZE on TYR expression in B16 cells was also examined
by western blotting analysis. As shown in Figure 5, the leveln Mr (relative
molar mass)
















Figure 2 The effect of KZE on mushroom tyrosinase activity.
Mushroom tyrosinase activity was determined by L-DOPA oxidation
in a cell-free system. Stimulation of tyrosinase activity in vitro by KZE
at 0.3125-5 mg/ml. MOP being positive controls at 500 μM. Results
shown are means ± SEM and are representative of three independent
experiments. Data were analyzed by One-Way Analysis of Variance
(ANOVA) followed by post hoc Tukey test. **P < 0.01, compared
with control.
Effect of KZ E on tyrosinase activity ( in B16 cells
Effect of KZ E on melanin content in B16 cells
A.
B.
Tuerxuntayi et al. BMC Complementary and Alternative Medicine 2014, 14:166 Page 6 of 9
http://www.biomedcentral.com/1472-6882/14/166of TYR protein expression was up regulated by KZE treat-
ment in a time-dependent manner.Figure 4 Tyrosinase activity was determined by L-DOPA
oxidation. A. Stimulation of tyrosinase activity of B16 cell by KZE at
5-40 μg /ml. B. Melanin content were performed as described in
"Materials and methods", B16 cells, the same by KZE at 5-40 μg /ml.
MOP being positive controls at 50 μM. Results shown are means ± SEM
and are representative of three independent experiments. Data were
analyzed by One-Way Analysis of Variance (ANOVA) followed by post
hoc Tukey test. **P<0.01, compared with control.Effect of KZE on TRP-1 and TRP-2 protein expression in
B16 cells
To elucidate whether KZE can affect melanogenic pro-
tein expression, western blotting was carried out using
lysates of B16 murine melanoma cells treated with KZE
(20 μg/ml).The expression of TRP-1 and TRP-2 in-
creased compared with the control (Figure 6). TRP-1
and TRP-2 protein expression was up regulated by KZE
in a time-dependent manner in the B16 cell.
In our study, the positive effect of KZE on melanogen-
esis in B16 cell lines was investigated to clarify its under-
lying molecular mechanism. To evaluate the biological
activity of KZE in melanin synthesis, we first examinedFigure 3 Cytotoxicity of KZE in B16 melanoma cells. Effect of
KZE on B16 cell viability. B16 cells were treated for 48 h with various
concentrations of KZE (6.25-800 μg/ml) and cell viability was
determined by the MTT reduction assay. Data are expressed as
mean ± SD (n = 6).its potential cytotoxicity in B16 cells. As shown in Figure 3,
KZE had no cytotoxic effect at concentrations of 1–50 μg/
ml, but it observably increased B16 cell proliferation.
Because it has been reported that melanin content dir-
ectly correlated with the activity of tyrosinase and its
protein levels [26], the effect of KZE on tyrosinase activ-
ity and expression was further explored. As expected,
KZE significantly increased both tyrosinase activity and
melanin synthesis in a concentration-dependent manner
(Figure 4A and B). These results suggest that KZE up
regulated tyrosinase activity and enhanced cellular mel-
anin synthesis in B16 cells. KZE affected tyrosinase
activity at concentrations of 10–40 μg/ml in B16 cells
(Figure 4A and B); we chose 20 μg/ml for the following
experiments. To clearly elucidate the molecular mecha-
nisms of KZE-induced actions, the effect of KZE on mela-
nogenic protein expression was examined. As MITF plays
an important role in melanogenesis as the major transcrip-
tion regulator of TYR [27-29], the expression of MITF and
TYR after treatment with 20 μg/ml KZE at 0–72 h was
Figure 6 Effect of KZE on the protein levels of TRP-1 and TRP-2 in B16 cells. The cells were treated with 20 μg/ml of KZE for the indicated
times. Western blot assays were performed to examine TRP-1 and TRP-2 expression levels. Results were normalized against β-actin expression.
Results shown are means ± SEM and are representative of three independent experiments. Data were analyzed by One-Way Analysis of Variance
(ANOVA) followed by post hoc Tukey test **P < 0.01, compared with control.
Figure 5 Effect of KZE on the protein levels of MITF and tyrosinase in B16 cells. The cells were treated with 20 μg /ml of KZE for the
indicated times. Western blot assays were performed to examine MITF and tyrosinase expression levels. Results were normalized against β-actin
expression. Results shown are means ± SEM and are representative of three independent experiments. Data were analyzed by One-Way Analysis
of Variance (ANOVA) followed by post hoc Tukey test **P < 0.01, compared with control.
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creased TYR and MITF levels 72 h and 48 h after treat-
ment, respectively.
TRP-1 and TRP-2 are transmembrane proteins span-
ning melanosomal membranes and may act together to
modulate TYR activity. TRP-1 has been reported to influ-
ence TYR activity by forming a complex with it and/or
stabilizing it [30]. TRP-2 functions as a dopachrome tau-
tomerase downstream of TYR in the melanogenic path-
way or the quantity and quality of the melanin produced
during melanin biosynthesis [31]. As shown in Figure 6,
KZE significantly increased the expression of TRP-1 and
TRP-2 at 48 h in B16 cells.
Conclusions
In conclusion, our results indicate that KZE induces me-
lanogenesis by increasing the expression level of tyrosin-
ase, TRP-1 and TRP-2 via MITF in B16 cells. The results
provide an interesting insight into the mechanism of
action of traditional Uyghur medicine in the treatment
of vitiligo.
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